Physician profile
Travis King
NPI 1659904407
$1,855.61
in general payments reported to CMS, 2019-2025
21 companies · $648 in 2025
The $648 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $430 · 2023: $76.96 · 2024: $579 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Invivyd INC | $299.39 | 2024-2025 | Pemgarda |
| Melinta Therapeutics, LLC | $281.25 | 2022 | |
| La Jolla Pharmaceutical Company | $187.46 | 2024-2025 | Xacduro, Giapreza |
| Merck Sharp & Dohme LLC | $183.74 | 2024-2025 | Verquvo, Keytruda |
| Medtronic, INC. | $170.43 | 2021-2024 | Invos |
| Boston Scientific Corporation | $144.15 | 2024-2025 | Watchman Flx, Emblem Mri S-Icd, Synergy |
| Baxter Healthcare | $120.23 | 2025 | Tisseel |
| Abiomed | $72.19 | 2022-2024 | Impella |
| Chiesi USA, INC. | $55.30 | 2022-2024 | Cleviprex, Kengreal |
| Novo Nordisk INC | $51.38 | 2025 | Wegovy, Ozempic |
| Lexicon Pharmaceuticals, INC. | $43.58 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.22 | 2024 | Lifevest |
| Aimmune Therapeutics, INC. | $34.33 | 2025 | Vowst |
| Kestra Medical Technology Services, INC. | $33.77 | 2023-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.35 | 2025 | Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $26.34 | 2025 | |
| Pfizer INC. | $18.66 | 2022 | |
| Lilly USA, LLC | $17.99 | 2022 | |
| Terumo Medical Corporation | $14.75 | 2023 | Glidewire, Angio-Seal, Metacross Otw |
| Alon Medical Technology | $14.67 | 2025 | |
| Btg International INC. | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.